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The microstructure, mechanical property, electrochemical behavior and biocompatibility of magnesium alloy (BioDe MSM™) were studied in
the present work. The experimental results demonstrated that grain reﬁning induced by extrusion improves the alloy strength signiﬁcantly from
162 MPa for the as-cast alloy to 241 MPa for the as-extruded one. The anticorrosion properties of the as-extruded alloy also increased.
Furthermore, the hemolysis ratio was decreased from 4.7% for the as-cast alloy to 2.9% for the as-extruded one, both below 5%. BioDe MSM™
alloy shows good biocompatibility after being implanted into the dorsal muscle and the femoral shaft of the New Zealand rabbit, respectively, and
there are no abnormalities after short-term implantation. In vivo observation indicated that the corrosion rate of this alloy varies with different
implantation positions, with higher degradation rate in the femur than in the muscle.
& 2014 Chinese Materials Research Society. Production and hosting by Elsevier B.V. All rights reserved.
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Recently, the materials extensively used in the clinical applica-
tions mainly include stainless steel, cobalt-based alloy and titanium
alloy. However, these biomedical metallic materials have their own
disadvantages. For example, wear debris and metal ions (Cr, Ni, V,
Al etc.) [1–3] resulting from abrasion of the material in vivo might
have cytotoxicity, cause local hypersensitivity or inﬂammation [4],
decrease biocompatibility and lead to tissue necrosis. Additionally,
the unmatched mechanical performance especially the elastic
module of these conventional materials shall induce stress shielding
effect [5,6], and increase the liability of secondary bone fracture
[7]. Moreover, these materials could not be biodegraded in vivo, so
they need to be taken out through operation after the human body
function restoration [8]. The biodegradable materials under devel-
opment nowadays have been focused on the polymers and some
ceramics. However, for the former, the mechanical strength is
usually poor, and brittleness is a big problem for the latter./10.1016/j.pnsc.2014.09.002
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nder responsibility of Chinese Materials Research Society.As a new revolutionary biomedical metallic material, Mg alloy
has been put special focus [9]. It could be used as biodegradable
material in medical ﬁeld since Mg alloy has active chemical
property [10,11] and is liable to be corroded in the physiological
environment after implantation without causing any toxic and side
effects [12]. Mg ions play a very important role in metabolism
[13,14], of which the content is only inferior to potassium ions in
human body. As a main constituent of living body bone, Mg
could boost the formation of teeth and bone and play a regulating
role in the metabolism of the mineral substance of the bone [15].
Further, mechanical performances such as plasticity, stiffness and
processability of Mg alloys are superior to those of the bioresorb-
able polymers, e.g. polylactic acid, in extensive clinical use [16].
Mg and its alloys are suitable to be used in the blood vessel
intervention and orthopedics due to the close elastic modulus to
that of bone [17–20]. The most delighted thing to the researchers
is that to date there is no adverse case report globally on the Mg
alloys implanted in blood vessel or bone in the animal studies [21].
The elastic deformation capability of Mg alloy is acknowl-
edged to be poor. However, Mg alloy with high elasticity could
be obtained by extrusion, because extrusion could induce more
intensive three-dimensional compressive stress in comparisonElsevier B.V. All rights reserved.
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reﬁne the grain, and accordingly the as-extruded Mg alloy is
promising [23,24].
In this study, a new medical biodegradable Mg alloy (BioDe
MSM™) was developed, and the feasibility of BioDe MSM™
alloy as biodegradable implant was investigated through micro-
structure observation, mechanical property testing, corrosion test-
ing, in vitro hemocompatibility analysis and in vivo animal studies.
2. Materials and methods
2.1. Alloy melting
The BioDe MSM™ alloy composition used in the present work
was Mg–3 wt%Sn–0.5 wt%Mn. The pure Mg ingots, Mg–Mn
master alloy and pure Sn ingots, calculated according to the above
formula were added to the electric-resistance crucible and heated to
approximate 740 1C with protection of RJ-2 covering agent. After
the alloys were fullly melted, the melt was stirred for 10 min for
homogenization and then remained for 10 min. After that, the alloy
melt was eventually casted with the protection of mixture gas of
CO2/SF6 at 720 1C.
2.2. Extrusion process
Four-column hydraulic press (YA32-200A) manufactured
by Tianjin Metal Forming Machine Tool Works was utilized in
the present work. The raw material size was ∅40 mm in diameter
and 250 mm in length, Forward extrusion was adopted at the
temperature of 370 1C, with a extrusion rate of 1.5 m/min, an
extrusion ratio of 20 and lubrication of colloidal graphite.
2.3. Microstructure and phase analysis
Axiovert 200 MAT metallurgical microscope was used for
microstructure observation. The extruded samples were degreased
with acetone ﬁrstly, and then grinded with 1000#, 1500# and
2000# abrasive paper followed by polishing. The polished sample
surface was ﬁrst eroded with 3% nitric acid for 10 s, and then with
5% picric acid for 10–20 s.
Philips X0Pert PRO X-ray diffraction system was used to
analyze the phase constitution of the as-extruded Mg alloys with
CuKα as X ray source, Kα1 with λ of 1.541, Kα2 with λ of 1.544,
Kα1/Kα2=0.5 and the scanning angle range as 20–801. Jade5 soft
was used for result analysis.
2.4. Mechanical property testing
Tensile properties were tested using universal (Instron 3365,
USA) with a crossing head rate of 0.5 mm/min. At least 3
effective data were obtained for each sample group to ensure
the statistical analysis.
2.5. Electrochemical corrosion test
Galvanostat/potentiostat (EG&G PAR 273) was used for
corrosion test. A three-electrode system was employed whichwas composed of a counter electrode of platinum foil, a reference
electrode of saturated calomel electrode and a work electrode
of tested sample. The electrolyte volume was 200 ml and the
exposure area was 0.283 cm2 for the test samples. The scanning
potential range was 2.0–0.8 V with a scanning rate of
0.01 mV/s.
2.6. Hemolysis
The cleaned samples were in the silanized glass tube. 10 ml
0.9%NaCl solution was added in to the tube, and then kept in a
37 1C water bath for 30 min. 0.2 ml fresh diluted blood with
anticoagulant was added to the tube, shaken slightly for better
mix and kept in the water bath for 60 min, and then be
centrifuged for 5 min. In the same condition, 10 ml 0.9%NaCl
solution with 0.2 ml fresh diluted blood with anticoagulant was
taken as negative control, and 10 ml distilled water with 0.2 ml
fresh diluted blood with anticoagulant was taken as positive
control. The supernatants after centrifugation were transferred
to cuvettes for absorbency testing using spectrophotometer at a
wavelength of 545 nm. Hemolysis was calculated according to
the following formula:
Hemolysis ¼ ½AbsorbancyðtestÞAbsorbancy
ðnegative controlÞ=½Absorbancyðpositive controlÞ
Absorbancyðnegative controlÞ  100%
2.7. Animal testing
Ten adult rabbits (provided by the Animal Experiment
Center of the 2nd afﬁliated Hospital of Harbin Medical
University) with 2.0–2.5 kg weight were randomly divided
into 3 groups with two rabbits in each group (marked group
A and group B for the test samples and a control group). Mg
alloy samples were implanted in the dorsal muscle in group A
and in the femoral bone in group B.
Blood samples for biochemical test (UniCelDxC 800, BECK-
MAN COULTERCo. Ltd.) were taken from marginal ear vein of
the rabbits before experiment and at different implantation time-
points. X-ray examination (MIKASA HF100H, MIKASA X-RAY
Co. Ltd.) was carried out on the implanted area at different follow-
up times for observation of the implant degradation. Rabbits
were sacriﬁced at the planned time points using 0.3% sodium
pentobarbital solution for overdose an aesthesia, and the organ
tissue samples of the heart, liver, kidney, spleen etc. were obtained.
Pathological examination with HE staining was conducted for
observation of any pathological changes around the implant.
3. Results and discussion
3.1. Microstructures
Fig. 1 shows the metallographic structure of BioDe MSM™
alloy at different conditions. It can be seen that the micro-
structure of as-cast alloy is inhomogeneous dendrite with the
grain size differs greatly. Secondary phase mainly precipitates
in the grain boundary and in the form of small particles of
Fig. 1. Microstructure patterns of BioDe MSM™ alloy: (a)as-cast and (b)as-extruded.
Fig. 2. XRD patterns of BioDe MSM™ alloy.
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obviously reﬁned and the grain size is smaller than the as-cast
structure. This is attributed to magnesium alloy's dynamic
recrystallization in hot extrusion process [25] accompanied by
the large deformation and high deformation temperature. Fig. 2
displays the XRD spectra of BioDe MSM™ alloy at different
conditions, and the secondary phase can be indexed as Mg2Sn.1E-6 1E-5 1E-4 1E-3 0.01
-2.0
Curren Density (A/cm2)
Fig. 4. Potentiodynamic polarization curves of BioDe MSM™ alloys in
different conditions.
Table 1
Average electrochemical parameters of BioDe MSM™ alloys in different
condition.
BioDe MSM™ alloy Ecorr (V) Icorr (μA/cm2)3.2. Mechanical property
Fig. 3 shows tensile test results of as-cast and as-extruded
BioDe MSM™ alloy. It can be seen that the tensile strength of
as-extruded BioDe MSM™ alloy is higher than that of the as-
cast one with an increment of 80 MPa. As shown in Fig. 1, ﬁne
grain was obtained in the extruded alloy due to dynamic
recrystallization during hot extrusion, resulting in grain reﬁn-
ing strengthening. After extrusion, Mg alloys exhibits high
ductility and the elongation rises to 22%.As-cast 1.80 26.9
As-extruded 1.61 2.313.3. Electrochemical measurement
Fig. 4 shows the potentiodynamic polarization curves of
BioDe MSM™ alloy in as-cast and as-extruded states. As
shown in Fig. 4, as-cast and as-extruded Mg alloys show quite
similar polarization behavior. The corrosion potential of as-extruded alloy is higher than that of as-cast alloy, but there is
no obvious difference between them. Table 1 presents the
average electrochemical parameters calculated for the BioDe
MSM™ alloy according to AS™ G102. It is obvious that the
Fig. 5. The X-ray imaging of BioDe MSM™ samples inter-femur bone implanted in rabbit.
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(1.61 V) is superior to that of as-cast BioDe MSM™ alloy
(1.80 V), and the result of corrosion current (Icorr) indicates
that as-extruded BioDe MSM™ alloy (2.31 μA/cm2) is
more resistant to corrosion than as-cast alloy (26.9 μA/cm2).
According to the electrochemical results listed in the Table 1,
as-extruded BioDe MSM™ alloy exhibits excellent antic-
orrosion properties over as-cast magnesium alloy.
3.4. Blood compatibility
The hemolysis rate of the as-cast BioDe MSM™ alloy is
4.7%, which is in the acceptable range of human body (5%).
The hemolysis rate of the as-extruded BioDe MSM™ alloy is
2.9%. For both the as-cast and as-extruded BioDe MSM™
alloy, the hemolysis is below the recommended value of 5%
according to ISO 10993-4:2002.
3.5. Animal implant experiments
Fig. 5 shows the X-ray manifestations at different time points
after the implantation of the extruded BioDe MSM™ alloy.
A large amount of gas aggregated around magnesium alloy rod,
as shown in Fig. 5(b) and (h).This is because of generated
hydrogen gas, which derived from reaction with body ﬂuid for
the implanted the magnesium alloy. Gas accumulated in the ﬁbrous
capsule to form a visible air mass because of the hysteresis and
limitedness of metabolism, thus the amount of gas formed in per
unit time was too large, beyond the ability of the body to normally
metabolize the gas, to be effectively metabolized. However, as time
prolonged, the gas mass appearing in the early stage of implanta-
tion disappeared (as shown in Fig. 5(e) and (i)), illustrating that the
hydrogen produced by magnesium alloy degradation could be
normally metabolized and excreted, which was considered to berealized through some ways of the body, such as gas was absorbed
by the body into the blood and exhausted through the lung, and the
comparison of X ray examination suggested that gas around the
femur disappeared earlier than that around back muscles, and it
may be caused by the activity of experimental animals. The blood
circulation in the implantation sites (the outer end of femur) was
exuberant and the metabolism of the gas was faster. Witte et al.
[26] and Zhang et al. [27] also found the gas mass in the ﬁbrous
capsule around the magnesium alloy in animal experiment, which
can be rapidly absorbed, and the gas release in the degradation
process of magnesium did no harm to the animal body. More-
over, Gao et al. [28] indicated that an appropriate release rate
of hydrogen would not cause damage to the body, and on
the contrary, it played a role in eliminating free radical and
inﬂammation.
As can be seen in Fig. 5, magnesium alloy rod implanted
into different positions showed different degradation rates. The
degradation rate of the rod implanted into subcutaneous tissue
was relatively slow. The alloy rod almost shows no signs of
degradation in the second week. Obvious degradation feature
was observed on the surface of alloy rod at the fourth week
and the sixth week. The implant is still remained in the tenth
week, but the volume was reduced in a large scale, yet the
remainder was still intact. The alloy implanted into femur
exhibited a more rapid corrosion rate, as obvious feature of
degradation could be observed in the fourth week. The alloy
rod deepening into the bone marrow cavity displayed fuzzy
and rough surface, and the alloy embedded deeply into the
bone cavity degraded seriously in the sixth week, with smaller
diameter and serious fuzziness and roughness. Until the tenth
week, the alloy rod could not be fully developed and the main
part of the rod was degraded, leaving only a small amount of
residual alloy in irregular shape. It is considered that the
different degradation behavior was derived from the different
L. Hou et al. / Progress in Natural Science: Materials International 24 (2014) 466–471470implantation position in the body. The slower degradation
speed of the alloy rod was caused by the wrapping by the
tissue when the material was implanted into the back. When
implanted into femur, the degradation speed was faster because
most of the alloy bar was located in the bone marrow cavity
and it suffered from scouring by body ﬂuid. Yang et al. [29]
carried out an AZ31 alloy experiments in vivo and proved that
the different environment of the implantation played a impor-
tant role in the degradation of magnesium alloy in vivo.
In previous work [30], magnesium ion concentration in serum
ﬂuctuate each time point within 1.15–1.75 mmol/L range, where
the normal range of serum magnesium concentration in experi-
mental animals is 0.82–2.22 mmol/L. Serum magnesium concen-
trations in the present experimental animals during the different
periods after surgery is shown in Fig. 6. Seen from Fig. 6, Mg2þ
concentration at 1 day post implantation reaches a peak concentra-
tion between 1.6 and 1.8 mmol/L, then decreases in the following
the other days. The degradation of BioDe MSM™ alloy implants0 7 14 21 28 35 42 49 56
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Fig. 7. Histological images of abdominals rabbits organs after 4 weekhas little effect on the blood concentration of magnesium ion,
which indicates liver and kidney function in experimental animals
are in good condition and the excess Mg2þ was excreted in
experimental animals. Hartwig [25] believed that intake of a high
concentration of magnesium ions would not cause adverse
reactions, Powerful excretory system of kidney and storage buffer
function of bones can make the body to maintain balance serum
magnesium concentration.
Fig. 7 is the histological images of rabbit abdominal organs after
4 weeks of inter-muscle implantation of BioDe MSM™ alloy
samples, including heart (Fig. 7(a) and (e)), liver (Fig. 7(b) and (f)),
kidneys (Fig.7(c) and (g)), and spleen (Fig.7(d) and (h)). All organs
show no obvious abnormalities. The cell structure does not change
in the morphology, and no inﬂammatory cell inﬁltration. These
results indicate that BioDe MSM™ alloy showed good biocom-
patibility with animal organs (heart, liver, kidney, spleen). It can be
inferred that the alloy implanted in animals at the early stage is
biosafe, experimental animals is tolerated with degradation pro-
ducts of BioDe MSM™ alloy.
4. Conclusions(1)   
s ofThe microstructure of extruded BioDe MSM™ alloy becomes
more homogeneous compared to that of as-cast alloy and the
grains are signiﬁcantly reﬁned. Being different from the
uneven distribution (granular) in as-cast BioDe MSM™ alloy,
the precipitated Mg2Sn phases are distributed along the grain
boundary in the form of small particles in extruded alloy.(2) The comprehensive mechanical properties of BioDe
MSM™ alloy have been notably improved by the extru-
sion. The tensile strength and elongation of the extruded
alloy are 241 MPa and 22%, respectively. Besides, the
anticorrosion properties of extruded BioDe MSM™ alloy
are superior to that of as-cast alloy.(3) In vivo test indicates that magnesium concentration in the
serum ﬂuctuates in the normal range, and there are no notablyKidney Spleen
h
  d
inter-muscle implantation of magnesium alloy samples.
L. Hou et al. / Progress in Natural Science: Materials International 24 (2014) 466–471 471histological changes for the various organs and tissues. This
result suggests that the implantation of BioDe MSM™ alloy
do not produce adverse impacts on body ﬂuid circulation,
immune and urinary system of the studied animals, conﬁrming
high biosafety of BioDe MSM™ alloy. Due to the good
mechanical properties, blood biocompatibility and biosafety,
the extruded BioDe MSM™ shows great potential for novel
medical implant material.Acknowledgments
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